Capital Access & Adoption

OBIO® supports early-stage and venture-backed life sciences and health tech companies by enabling them to:

  • Raise capital

  • Train their start-up teams

  • Develop early commercialization strategies

  • Drive market adoption through connections with healthcare systems, and strategic MedTech & Pharma partners

  • Access critical infrastructure resources

From a commercialization perspective, we support early-stage companies with technology and commercial development by providing real-time advice on securing angel capital through HealthMINT®. As companies transition from Seed to Series A, we offer two competitive programs: CAAP®, which prepares executive teams for financing, and EAHN™, which supports commercial adoption and procurement.


Some companies OBIO® has supported over the years:


Have a question? Contact us:

Jack Lee
Senior Director, Capital Access
jacklee@obio.ca